Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: BOSTON MEDICAL CENTER CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-28 to 2025-11-30
Current total value of award: $126095
Description: NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE FY22 CAN 8054183